Marion Biotech stops production of cough syrup linked to death of 18 kids in Uzbekistan, CDSCO initiates probe
"The company does not have any domestic market and has only one export market which is Uzbekistan. No product (Doc-1 Max) has been sold in India," the drug inspector told PTI.
Noida: A team of central agencies and the Uttar Pradesh drug department on Thursday carried out an inspection at the Noida office of a pharmaceutical firm whose cough syrup is allegedly linked to the death of 18 children in Uzbekistan, officials said.
The company, Marion Biotech, does not sell the cough syrup, 'Doc-1 Max', in India and its only export has been to Uzbekistan, a state government official said.
The inspection began at Marion Biotech's office in Noida Sector 67 on Thursday morning, Gautam Buddh Nagar Drug Inspector Vaibhav Babbar told PTI.
The Central Drugs Standard Control Organisation (CDSCO) has initiated a probe in connection with the death of 18 children in Uzbekistan allegedly linked to Marion Biotech.
The health ministry of Uzbekistan has claimed that 18 children had consumed the cough syrup.
Hasan Harris, legal representative of Marion Biotech, said the governments of both countries are looking into the matter and inquiring.
"There is no problem from our end and no issue in testing. We have been there for the past ten years. Once the government report will come, we will look into it. For now the manufacturing has stopped," Harris said. Babbar said on December 27, an inspection was carried out by a team of the Centre in which samples of five medicines were taken for testing.
"A further round of investigation is pending for which we have come here today," he said.
"The company does not have any domestic market and has only one export market which is Uzbekistan. No product (Doc-1 Max) has been sold in India," the drug inspector told PTI.
The company is currently operational and they have all mandatory licenses and approvals, including certificate of pharmaceutical product (CoPP) for export which is granted by the Centre, he said.
"Now the investigation underway is to find out from where they procured the raw material and where all it has been used," he said.
The company has been operational since 2010, he added.
Meanwhile, when checked by PTI, the website of Marion Biotech became inaccessible Thursday morning.
"Error establishing a database connection (sic)," read a message on the homepage of marionbiotech.com.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.